| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/10/2013 | WO2012099832A3 Enzymatic ligation of nucleic acids |
| 01/10/2013 | WO2012094425A4 Biological methods for preparing adipic acid |
| 01/10/2013 | WO2012092327A3 Methods to determine zygosity in a bulked sample |
| 01/10/2013 | WO2012083072A3 LIGATION METHOD EMPLOYING EUKARYOTIC tRNA LIGASE |
| 01/10/2013 | WO2012082753A3 Polymerization of nucleic acids using activation by polyphosphorolysis (app) reactions |
| 01/10/2013 | WO2012074868A3 Optimized expression of glyphosate resistance encoding nucleic acid molecules in plant cells |
| 01/10/2013 | WO2012058458A3 Method for increasing the efficiency of double-strand break-induced mutagenesis |
| 01/10/2013 | WO2012048334A3 Novel fungal proteases |
| 01/10/2013 | WO2010055187A3 Use of rnase p as antiviral agent |
| 01/10/2013 | US20130014294 Site-specific integration and stacking of transgenes in soybean via dna recombinase mediated cassette exchange |
| 01/10/2013 | US20130014293 Xylanase Variants and Polynucleotides Encoding Same |
| 01/10/2013 | US20130014292 Transgenic plants having increased biomass |
| 01/10/2013 | US20130014291 Cytokinin Oxidase-Like Sequences and Methods of Use |
| 01/10/2013 | US20130014290 Udp-xylose synthases (uxs) polynucleotides, polypeptides and uses thereof |
| 01/10/2013 | US20130014289 Genes conferring stress tolerance in plants and uses thereof |
| 01/10/2013 | US20130014288 Novel reporter-tagged recombinant membrane proteins with transmembrane linkers |
| 01/10/2013 | US20130012574 Compositions and Methods for Enhanced Parvovirus Transduction |
| 01/10/2013 | US20130012573 Methods for intracellular delivery of nucleic acids |
| 01/10/2013 | US20130012572 Compositions And Methods For Inhibiting Expression Of GSK-3 Genes |
| 01/10/2013 | US20130012570 GNAQ TARGETED dsRNA COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION |
| 01/10/2013 | US20130012567 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/10/2013 | US20130012527 Preq1 riboswitches and methods and compositions for use of and with preq1 riboswitches |
| 01/10/2013 | US20130012471 Means and methods for producing artificial capsular polysaccharides of neisseria meningitidis |
| 01/10/2013 | US20130012455 Use of ARC for inhibiting cell death during liver failure |
| 01/10/2013 | US20130012437 Lytic peptides having anti-proliferative activity against prostate cancer cells |
| 01/10/2013 | US20130012424 Pectate Lyase Variants |
| 01/10/2013 | US20130011920 Methods for Reducing Protein Levels in a Cell |
| 01/10/2013 | US20130011919 Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof |
| 01/10/2013 | US20130011916 Construction and use of transfection enhancer elements |
| 01/10/2013 | US20130011909 Methods and composition to enhance production of fully functional p-glycoprotein in pichia pastoris |
| 01/10/2013 | US20130011903 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities |
| 01/10/2013 | US20130011898 Genetically Modified Phage and Use Thereof |
| 01/10/2013 | US20130011890 Whole cell biocatalyst |
| 01/10/2013 | US20130011888 Production of geranyl diphosphate |
| 01/10/2013 | US20130011882 Alpha-amylase variants with altered properties |
| 01/10/2013 | US20130011878 Antigen binding proteins that bind par-2 |
| 01/10/2013 | US20130011877 Kex2 cleavage regions of recombinant fusion proteins |
| 01/10/2013 | US20130011876 Process for preparing filamentous fungal strains having a sexual cycle and a process for preparing sexually crossed filamentous fungal strains |
| 01/10/2013 | US20130011874 Reduced genome e. coli |
| 01/10/2013 | US20130011873 Enzyme that catalyzes a peptide-forming reaction from a carboxy component and an amine component, microbe producing the same, and a method of producing a dipeptide using the enzyme or microbe |
| 01/10/2013 | US20130011858 Methods for predicting pregnancy outcome in a subject by hcg assay |
| 01/10/2013 | US20130011846 Delta 17 desaturase and its use in making polyunsaturated fatty acids |
| 01/10/2013 | US20130011839 Methods for the Reduction of Stutter in Microsatellite Amplification |
| 01/10/2013 | US20130011838 Kits And Methods For Assessing Oxidative Stress |
| 01/10/2013 | US20130011828 Use |
| 01/10/2013 | US20130011436 Methods and Compositions Containing Fc Fusion Proteins for Enhancing Immune Responses |
| 01/10/2013 | US20130011435 Composition for treating hbv infection |
| 01/10/2013 | US20130011433 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 |
| 01/10/2013 | US20130011432 Disrupted adenovirus-based vaccine against drugs of abuse |
| 01/10/2013 | US20130011428 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/10/2013 | US20130011427 Flavivirus species-specific peptide tags for vaccine and diagnostic use |
| 01/10/2013 | US20130011426 Recombinant Vaccines and Use Thereof |
| 01/10/2013 | US20130011425 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/10/2013 | US20130011424 Polyepitope constructs and methods for their preparation and use |
| 01/10/2013 | US20130011422 Tumor Antigens for the Prevention and/or Treatment of Cancer |
| 01/10/2013 | US20130011418 Antibody-Drug Conjugates |
| 01/10/2013 | US20130011412 Antibodies to lymphotoxin-alpha |
| 01/10/2013 | US20130011409 Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1 |
| 01/10/2013 | US20130011406 Anti-kit antibodies and uses thereof |
| 01/10/2013 | US20130011401 Soluble proteins for use as therapeutics |
| 01/10/2013 | US20130011394 Complexes comprising mhc class i fusion polypeptides and antigen-specific antibodies and methods of use |
| 01/10/2013 | US20130011380 Use of Cytidine Deaminase-Related Agents to Promote Demethylation and Cell Reprogramming |
| 01/10/2013 | US20130011376 Methods for Enhancing Natural Killer Cell Proliferation and Activity |
| 01/10/2013 | US20130011375 T cell receptors specific for immunodominant ctl epitopes of hcv |
| 01/10/2013 | US20130011372 Inactivated microorganisms containing double -strand rna molecules (dsrna), their use as pesticides and methods for their preparation |
| 01/10/2013 | US20130011371 ESTABLISHMENT OF PATIENT- OR PERSON- SPECIFIC CARDIAC MYOCYTE CELL LINES FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (iPSCs) |
| 01/10/2013 | US20130011367 Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis |
| 01/10/2013 | US20130011366 Therapeutic Agent for infections, and treatment method using the same |
| 01/10/2013 | US20130011334 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
| 01/10/2013 | DE112011100643T5 Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation |
| 01/10/2013 | DE112009003677T5 Pflanzenwachstum fördernder Proteinkomplex Plant growth-promoting protein complex |
| 01/10/2013 | CA2852053A1 Enzymes that synthesize zingiberene |
| 01/10/2013 | CA2841805A1 Genetically modified phage and use thereof |
| 01/10/2013 | CA2841796A1 Biological methods for preparing a fatty dicarboxylic acid |
| 01/10/2013 | CA2841794A1 Biological methods for preparing a fatty dicarboxylic acid |
| 01/10/2013 | CA2841372A1 Agr2 blocking antibody and use thereof |
| 01/10/2013 | CA2840962A1 Alpha amylase variants and polynucleotides encoding same |
| 01/10/2013 | CA2840868A1 Hcv genotype 4 replicons |
| 01/10/2013 | CA2840828A1 Hcv genotype 3 replicons |
| 01/10/2013 | CA2840646A1 Methods and compositions for selective regulation of protein expression |
| 01/10/2013 | CA2840162A1 Constitutively active aba receptor mutants |
| 01/10/2013 | CA2839941A1 Recombinant low virulence bovine herpesvirus 1 (bohv-1) vaccine vectors |
| 01/10/2013 | CA2839840A1 Use of jaz5a for improving drought-resistance in a plant |
| 01/10/2013 | CA2839651A1 Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
| 01/10/2013 | CA2837760A1 Nucleotide sequences mutated by insertion that encode a truncated oleate desaturase protein, proteins, methods and uses |
| 01/10/2013 | CA2835607A1 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 01/10/2013 | CA2832369A1 Adeno-parvovirus chimera with enhanced oncolytical potential |
| 01/09/2013 | EP2544003A1 Caveolin-1 in tumor-associated fibroblasts as biomarker for tumor progression |
| 01/09/2013 | EP2543738A2 Random RNAi libraries, methods of generating same, and screening methods utilizing same |
| 01/09/2013 | EP2543737A2 Method for detecting nucleic acids by promoting branched dna complex formation |
| 01/09/2013 | EP2543736A1 Method for producing 1,5-pentamethylene diamine, 1,5-pentamethylene diamine, 1,5-pentamethylene diisocyanate, method for producing 1,5-pentamethylene diisocyanate, polyisocyanate composition, and polyurethane resin |
| 01/09/2013 | EP2543735A1 Genes and uses for plant enhancement |
| 01/09/2013 | EP2543734A1 Adeno-parvovirus chimera with enhanced oncolytical potential |
| 01/09/2013 | EP2543733A1 Plants having improved characteristics and a method for making the same |
| 01/09/2013 | EP2543732A1 Plants transformed with a nucleic acid encoding chloroplastic fructose-1,6-bisphosphatase having increased yield, and a method for making the same |
| 01/09/2013 | EP2543731A1 Herbicide-resistant brassica plants and methods of use |
| 01/09/2013 | EP2543730A1 Antibody constant region variant |
| 01/09/2013 | EP2543729A1 Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor |
| 01/09/2013 | EP2543728A1 Process for production of useful substance using genetically modified streptomyces ray fungus |
| 01/09/2013 | EP2543727A1 Modified antibody composition |